Santhera Pharmaceuticals Holding(CH:SANN)
CHF 14.84-0.10 (-0.67%)
CH:SANN
Santhera Pharmaceuticals Holding Revenue
CHF 14.84
At close:-0.10 (-0.67%)
Want to see CH:SANN full AI Analyst Report?
Santhera Pharmaceuticals Holding (SANN) Revenue
6 Followers
Santhera Pharmaceuticals Holding Revenue
Santhera Pharmaceuticals Holding had a revenue of 48.33M in the quarter ending Sep 30, 2026, with -9.11%. This bring the company's revenue in the last twelve months to 101.50M, Increased 31.50%. In the fiscal year ending Mar 31, 2026, Santhera Pharmaceuticals Holding had annual revenue of 77.19M with 97.32% growth.
- Revenue (ttm)
- 101.50M
- Revenue Growth
- 107.08%
- P/S Ratio
- 2.97
- Revenue/Employee
- CHF 989,551
- Employees
- 78
- Market Cap
- CHF 228.87M
Revenue Chart
Santhera Pharmaceuticals Holding Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 77.19M | 38.07M | 97.32% |
| Mar 31, 2025 | 39.12M | -64.30M | -62.17% |
| Dec 31, 2023 | 103.41M | 95.94M | 1283.84% |
| Mar 31, 2023 | 7.47M | 9.07M | -568.53% |
| Dec 31, 2021 | -1.59M | -16.60M | -110.63% |
| Dec 31, 2020 | 15.01M | -60.37M | -80.09% |
| Dec 31, 2019 | 75.38M | 43.72M | 138.10% |
| Dec 31, 2018 | 31.66M | 8.71M | 37.98% |
| Dec 31, 2017 | 22.94M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.